Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
| Trades 395 | Longs Won 171/395 43% | Profit Factor 1.4 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $7,115.31 |
| Average Win $3,583.59 | Best Trade (Sep 06) $70,083.01 | Sharpe Ratio -53.91 |
| Average Loss -$1,953.82 | Worst Trade (Feb 28) -$35,743.05 | Z-Score -5.79 (100%) |
| Commissions $0 | Avg. Trade Length 1m 3w 3d | Expectancy $449.44 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | 0.04% | 0.29% | 1.16% | 3.44% | 8.34% | 17.65% | 33.79% | 59.91% |
| Consecutive Losing Trades | 142 | 128 | 114 | 99 | 85 | 71 | 57 | 43 | 28 | 14 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
BIIB Biogen Inc. | 458.9 | $95,657.16 | $94,661.35 | - | -$995.81 | -1.04% | -0.169% |
INCY Incyte Corporation | 793.18 | $95,657.16 | $95,022.61 | - | -$634.55 | -0.66% | 0.0 |
WVE Wave Life Sciences Ltd. | 15,942.86 | $95,657.16 | $87,845.15 | - | -$7,812.01 | -8.17% | -7.083% |